Long-circulating and target-specific nanoparticles: theory to practice.
暂无分享,去创建一个
[1] M. Yokoyama. Block copolymers as drug carriers. , 1992, Critical reviews in therapeutic drug carrier systems.
[2] John W. Park,et al. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. , 1997, Biochemistry.
[3] P. Low,et al. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. , 1994, The Journal of biological chemistry.
[4] B. Goins,et al. Blood-pool imaging using technetium-99m-labeled liposomes. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] D. Devine,et al. Liposome-complement interactions in rat serum: implications for liposome survival studies. , 1994, Biochimica et biophysica acta.
[6] D. Bazile,et al. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. , 1995, Journal of pharmaceutical sciences.
[7] R. Hunter,et al. CRL-1072 enhances antimycobacterial activity of human macrophages through interleukin-8. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[8] V. Torchilin,et al. CT visualization of blood pool in rats by using long-circulating, iodine-containing micelles. , 1999, Academic radiology.
[9] J. Kreuter,et al. Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants , 1990 .
[10] L. P. Yasenchak,et al. Tissue response to implanted polymers: the significance of sample shape. , 1976, Journal of biomedical materials research.
[11] J. V. Von Roenn,et al. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] V. Torchilin,et al. Targeted accumulation of polyethylene glycol‐coated immunoliposomes in infarcted rabbit myocardium , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] Leaf Huang,et al. Folate-targeted, Anionic Liposome-entrapped Polylysine-condensed DNA for Tumor Cell-specific Gene Transfer (*) , 1996, The Journal of Biological Chemistry.
[14] Olivier Meyer,et al. Copolymers of N‐isopropylacrylamide can trigger pH sensitivity to stable liposomes , 1998, FEBS letters.
[15] S. Armes,et al. Synthesis of Zwitterionic Shell Cross-Linked Micelles , 1999 .
[16] W. Oyen,et al. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. , 2000, The Journal of pharmacology and experimental therapeutics.
[17] J. Szebeni,et al. The interaction of liposomes with the complement system. , 1998, Critical reviews in therapeutic drug carrier systems.
[18] M. Naito,et al. Macrophage heterogeneity in development and differentiation. , 1993, Archives of histology and cytology.
[19] S. Seltzer. The role of liposomes in diagnostic imaging. , 1989, Radiology.
[20] G Gregoriadis,et al. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. , 1991, Biochimica et biophysica acta.
[21] David J. Yang,et al. Polyamino acid microspheres: Preparation, characterization and distribution after intravenous injection in rats , 1993 .
[22] R. Melton,et al. Covalent linkage of carboxypeptidase G2 to soluble dextrans--I. Properties of conjugates and effects on plasma persistence in mice. , 1987, Biochemical pharmacology.
[23] G. Gregoriadis,et al. Is half‐life of circulating liposomes determined by changes in their permeability? , 1982, FEBS letters.
[24] M. Kazatchkine,et al. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b. , 1979, Journal of immunology.
[25] D. Absolom. Opsonins and dysopsonins: an overview. , 1986, Methods in enzymology.
[26] T. Callisen,et al. Increase in phospholipase A2 activity towards lipopolymer-containing liposomes. , 1998, Biochimica et biophysica acta.
[27] W. Oyen,et al. Scintigraphic imaging of bacterial and fungal infection in granulocytopenic rats. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] S. Moghimi,et al. Altered tissue-specific opsonic activities and opsono-recognition of liposomes in tumour-bearing rats. , 1996, Biochimica et biophysica acta.
[29] D. Cabral,et al. Mucoid Pseudomonas aeruginosa Resists Nonopsonic Phagocytosis by Human Neutrophils and Macrophages , 1987, Pediatric Research.
[30] Moghimi,et al. Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography. , 1999, Advanced drug delivery reviews.
[31] Y. Nio,et al. A quinolinone derivative, vesnarinone (OPC-8212), significantly inhibits the in vitro and in vivo growth of human pancreatic cancer cell lines , 1997, Anti-cancer drugs.
[32] G. Gregoriadis,et al. Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection. , 1985, Biochimica et biophysica acta.
[33] V. Torchilin,et al. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. , 1991, Biochimica et biophysica acta.
[34] N. Van Rooijen,et al. Transient suppression of macrophage functions by liposome-encapsulated drugs. , 1997, Trends in biotechnology.
[35] S. Moghimi. Mechanisms of splenic clearance of blood cells and particles : towards development of new splenotropic agents , 1995 .
[36] H M Patel,et al. Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes. , 1989, Biochimica et biophysica acta.
[37] W. Phillips. Use of Radiolabeled Liposomes for PEG-Liposome-Based Drug Targeting and Diagnostic Imaging Applications , 1998 .
[38] B. Paton,et al. A study of labeled pluronic F-68 after intravenous injection into the dog. , 1978, The Journal of surgical research.
[39] R. Müller,et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.
[40] T. Allen,et al. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine. , 1992, Cancer research.
[41] J. Mulliken,et al. E-selectin is present in proliferating endothelial cells in human hemangiomas. , 1996, The American journal of pathology.
[42] Stephen E. Harding,et al. Polylactide−Poly(ethylene glycol) Copolymers as Drug Delivery Systems. 1. Characterization of Water Dispersible Micelle-Forming Systems , 1996 .
[43] L. Schook,et al. Mechanisms generating functionally heterogeneous macrophages: chaos revisited , 1993, Journal of leukocyte biology.
[44] D. Shotton,et al. Purification and properties of sialoadhesin, a sialic acid‐binding receptor of murine tissue macrophages. , 1991, The EMBO journal.
[45] H. Kikuchi,et al. Phosphatidyl polyglycerols prolong liposome circulation in vivo , 1994 .
[46] E. Moase,et al. Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. , 1995, Biochimica et biophysica acta.
[47] Suming Li,et al. Enzymatic degradation of stereocopolymers derived from L-, DL- and meso-lactides , 2000 .
[48] R Weissleder,et al. MR lymphography: study of a high-efficiency lymphotrophic agent. , 1994, Radiology.
[49] L. Huang,et al. Effect of chemically modified GM1 and neoglycolipid analogs of GM1 on liposome circulation time: evidence supporting the dysopsonin hypothesis. , 1993, Biochimica et biophysica acta.
[50] Devine,et al. The complement system in liposome clearance: Can complement deposition be inhibited? , 1998, Advanced drug delivery reviews.
[51] A. M. Lefer,et al. Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischaemia and reperfusion injury. , 1995, Cardiovascular research.
[52] W. Oyen,et al. Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[53] M. Bally,et al. The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: implications for drug delivery. , 1995, Biochimica et biophysica acta.
[54] R K Jain,et al. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. , 1990, Journal of the National Cancer Institute.
[55] K. Yamamoto,et al. Immunohistochemical phenotyping of liver macrophages in normal and diseased human liver , 1994, Hepatology.
[56] Kostas Kostarelos,et al. LIPOSOMES AS CARRIERS OF RADIONUCLIDES: FROM IMAGING TO THERAPY , 1999 .
[57] Erkki Ruoslahti,et al. αv Integrins as receptors for tumor targeting by circulating ligands , 1997, Nature Biotechnology.
[58] G. Matyas,et al. Complement-dependent phagocytosis of liposomes by macrophages: suppressive effects of "stealth" lipids. , 1991, Biochemical and biophysical research communications.
[59] D. Fearon,et al. Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[60] D. Crommelin,et al. Adhesion molecules: a new target for immunoliposome‐mediated drug delivery , 1995, FEBS letters.
[61] W. Oyen,et al. Detection of subacute infectious foci with indium-111-labeled autologous leukocytes and indium-111-labeled human nonspecific immunoglobulin G: a prospective comparative study. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[62] T. Allen,et al. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. , 1995, Biochimica et biophysica acta.
[63] M. Bally,et al. Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. , 1998, Biochimica et biophysica acta.
[64] S. Zalipsky. Functionalized Poly(ethylene glycol) for Preparation of Biologically Relevant Conjugates , 1995 .
[65] L. Weiss,et al. Anatomical hazards to the passage of erythrocytes through the spleen. , 1970, Seminars in hematology.
[66] J. Swanson,et al. Delivery of Macromolecules into Cytosol Using Liposomes Containing Hemolysin from Listeria monocytogenes(*) , 1996, The Journal of Biological Chemistry.
[67] Gert Storm,et al. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .
[68] D. Devine,et al. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. , 1991, Journal of immunology.
[69] Poloxamer-188 revisited: a potentially valuable immune modulator. , 1996, Journal of the National Cancer Institute.
[70] R. Steinman,et al. Liver macrophages in murine listeriosis. Cell-mediated immunity is correlated with an influx of macrophages capable of generating reactive oxygen intermediates , 1985, The Journal of experimental medicine.
[71] F. Davis,et al. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. , 1977, The Journal of biological chemistry.
[72] Thomas N. Sato,et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation , 1995, Nature.
[73] Amarpreet S. Sawhney,et al. Poly(ethylene glycol) , 1999 .
[74] R. Langer,et al. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. , 1997, Journal of pharmaceutical sciences.
[75] Y. Quinn,et al. New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine. , 1999, Bioconjugate chemistry.
[76] I. Kovesdi,et al. Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation , 1997, Cancer Immunology, Immunotherapy.
[77] Luke S. S. Guo,et al. Sialyl Lewis x Liposomes as a Multivalent Ligand and Inhibitor of E-Selectin Mediated Cellular Adhesion , 1996 .
[78] P. Couvreur,et al. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[79] G. Cornelis,et al. Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules , 1993, Infection and immunity.
[80] L. Hamilton,et al. Observations of cattle, goats and pigs after administration of synthetic interferon inducers and subsequent exposure to foot and mouth disease virus. , 1973, Canadian journal of comparative medicine : Revue canadienne de medecine comparee.
[81] J. Robert,et al. Failure of liposomal encapsulation of doxorubicin to circumvent multidrug resistance in an in vitro model of rat glioblastoma cells. , 1995, European journal of cancer.
[82] C. Alving,et al. Complement-Dependent Phagocytosis of Liposomes: Suppression by “Stealth” Lipids , 1992 .
[83] T. Tadros,et al. Physical Conjugation of (Tri-) Block Copolymers to Liposomes toward the Construction of Sterically Stabilized Vesicle Systems , 1999 .
[84] A. Gabizon,et al. Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. , 1991, Biochimica et biophysica acta.
[85] G. Gregoriadis,et al. Polysialylated asparaginase: preparation, activity and pharmacokinetics. , 1997, Biochimica et biophysica acta.
[86] C. Alving. Macrophages as targets for delivery of liposome-encapsulated antimicrobial agents , 1988 .
[87] M. Bally,et al. Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol). , 2001, Biochimica et biophysica acta.
[88] D. Mason,et al. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. , 1986, Immunology.
[89] M. Smith,et al. Human spleen contains phenotypic subsets of macrophages and dendritic cells that occupy discrete microanatomic locations. , 1987, The American journal of pathology.
[90] P. Crocker,et al. Sialic acid binding receptors (siglecs) expressed by macrophages , 1999, Journal of leukocyte biology.
[91] G. Storm,et al. Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. , 1993, Biochimica et biophysica acta.
[92] M. Telen,et al. Rh-related antigen CD47 is the signal-transducer integrin-associated protein. , 1994, The Journal of biological chemistry.
[93] L. Huang,et al. Effect of matrix lipid chain length on liposomes containing cholesterol and ganglioside GM1: implications in drug delivery. , 1996, Journal of pharmaceutical sciences.
[94] W. Oyen,et al. Technetium-99m-labeled liposomes to image experimental colitis in rabbits: comparison with technetium-99m-HMPAO-granulocytes and technetium-99m-HYNIC-IgG. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[95] M. Yatvin,et al. pH-sensitive liposomes: possible clinical implications. , 1980, Science.
[96] S. Ram,et al. A Novel Sialic Acid Binding Site on Factor H Mediates Serum Resistance of Sialylated Neisseria gonorrhoeae , 1998, The Journal of experimental medicine.
[97] T. Allen. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. , 1994, Trends in pharmacological sciences.
[98] Moghimi,et al. Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - The concept of tissue specificity. , 1998, Advanced drug delivery reviews.
[99] D. Birmingham,et al. Primate erythrocyte-immune complex-clearing mechanism. , 1983, The Journal of clinical investigation.
[100] M. Schmidt,et al. The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. , 1981, European journal of biochemistry.
[101] V. Perry,et al. Antigen markers of macrophage differentiation in murine tissues. , 1992, Current topics in microbiology and immunology.
[102] M. Dewhirst,et al. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[103] A. Surolia,et al. Monosialoganglioside liposome-entrapped enzyme uptake by hepatic cells. , 1977, Biochimica et biophysica acta.
[104] R. Jain,et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[105] D. Williams,et al. Enzyme-accelerated hydrolysis of polyglycolic acid. , 1977, Journal of bioengineering.
[106] S. Moghimi,et al. Differential properties of organ-specific serum opsonins for liver and spleen macrophages. , 1989, Biochimica et biophysica acta.
[107] P. D'Arcy Hart,et al. Effects of non‐ionic surfactants that modify experimental tuberculosis on lipase activity of macrophages , 1971, British journal of pharmacology.
[108] S M Moghimi,et al. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. , 2000, Trends in biotechnology.
[109] P. Stauffer,et al. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. , 1994, Cancer research.
[110] Erkki Ruoslahti,et al. Anti-cancer activity of targeted pro-apoptotic peptides , 1999, Nature Medicine.
[111] M. Sawada,et al. Effects of glycophorin and ganglioside GM3 on the blood circulation and tissue distribution of liposomes in rats , 1993 .
[112] T. Wileman. Properties of asparaginase-dextran conjugates , 1991 .
[113] J. Feijen,et al. The effect of phagocytosis of poly(L-lactic acid) fragments on cellular morphology and viability. , 1993, Journal of biomedical materials research.
[114] K. Higashi,et al. Effects of sialic acid derivative on long circulation time and tumor concentration of liposomes , 1995 .
[115] R. J. Lee,et al. Targeted drug delivery via the folate receptor. , 2000, Advanced drug delivery reviews.
[116] S. Davis,et al. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. , 1991, Biochemical and biophysical research communications.
[117] G. Frija,et al. MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement. , 1994, AJR. American journal of roentgenology.
[118] X. Wu,et al. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomers: Part II. Biodegradation and drug delivery application. , 1997, Journal of biomaterials science. Polymer edition.
[119] S. Benita. Kinetic model identification of drug release from microcapsules using the nonlinear regression search procedure. , 1984, Applied biochemistry and biotechnology.
[120] J. Feijen,et al. Cellular Uptake of PEO Surface-Modified Nanoparticles: Evaluation of Nanoparticles Made of PLA: PEO Diblock and Triblock Copolymers , 2000, Journal of drug targeting.
[121] L. Weiss,et al. Mechanisms of splenic control of murine malaria: reticular cell activation and the development of a blood-spleen barrier. , 1986, The American journal of anatomy.
[122] B. Lundberg. A Submicron Lipid Emulsion Coated with Amphipathic Polyethylene Glycol for Parenteral Administration of Paclitaxel (Taxol) , 1997, The Journal of pharmacy and pharmacology.
[123] N. Hogg,et al. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. , 1988, The Journal of clinical investigation.
[124] Y. Takei,et al. Liposome‐encapsulated dichloromethylene diphosphonate induces macrophage apoptosis in vivo and in vitro , 1996, Journal of leukocyte biology.
[125] P Couvreur,et al. Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. , 1997, Life sciences.
[126] D. Cheresh. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[127] T M Allen,et al. Large unilamellar liposomes with low uptake into the reticuloendothelial system , 1987, FEBS letters.
[128] Samuel Zalipsky,et al. Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface‐grafted poly(ethylene glycol) , 1996, FEBS letters.
[129] M. Poznansky,et al. Biological approaches to the controlled delivery of drugs: a critical review. , 1984, Pharmacological reviews.
[130] H. Bayley,et al. Tumor protease-activated, pore-forming toxins from a combinatorial library , 1996, Nature Biotechnology.
[131] C. Alving,et al. Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atherosclerosis and autoimmunity. , 1991, Critical reviews in immunology.
[132] K. D. Lee,et al. Bacterial pore-forming hemolysins and their use in the cytosolic delivery of macromolecules. , 2000, Advanced drug delivery reviews.
[133] M. Dierich,et al. Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55) , 1996, The Journal of experimental medicine.
[134] M C Davies,et al. Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer. , 1997, Biomaterials.
[135] Tomoo Suzuki,et al. Hydrolysis of polyesters by lipases , 1977, Nature.
[136] S. Benita,et al. Fundamentals of release mechanism interpretation in multiparticulate systems: determination of substrate release from single microcapsules and relation between individual and ensemble release kinetics , 1986 .
[137] H. Friess,et al. Over‐expression of ICAM‐1, VCAM‐1 and ELAM‐1 might influence tumor progression in colorectal cancer , 1998, International journal of cancer.
[138] W. R. Bruce,et al. Studies on the persistence of methotrexate, cytosine arabinoside, and leucovorin in serum of mice. , 1969, Journal of the National Cancer Institute.
[139] M C Garnett,et al. Preparation of surface-modified albumin nanospheres. , 1997, Biomaterials.
[140] I. Macdonald,et al. Microcirculation in mouse spleen (nonsinusal) studied by means of corrosion casts , 1985, Journal of morphology.
[141] S. Meri,et al. Localization of the heparin-binding site on complement factor H. , 1991, The Journal of biological chemistry.
[142] R. Means,et al. A role for carbohydrates in immune evasion in AIDS , 1998, Nature Medicine.
[143] D. Breslow. Biologically Active Synthetic Polymers , 1976 .
[144] A. Gabizon,et al. The role of surface charge and hydrophilic groups on liposome clearance in vivo. , 1992, Biochimica et biophysica acta.
[145] W. Oyen,et al. Sterically stabilized liposomes labeled with indium-111 to image focal infection. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[146] T. Allen,et al. Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes. , 1996, Journal of pharmaceutical sciences.
[147] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[148] C. G. Pitt,et al. Poly (glycolic acid-co-dl-lactic acid): diffusion or degradation controlled drug delivery? , 1992 .
[149] S. Stewart,et al. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[150] T. D. Madden,et al. LIPOSOMAL CYCLOSPORINE: CHARACTERIZATION OF DRUG INCORPORATION AND INTERBILAYER EXCHANGE , 1995, Transplantation.
[151] C. Bucana,et al. Enhancement of murine tumor cell sensitivity to adriamycin by presentation of the drug in phosphatidylcholine-phosphatidylserine liposomes. , 1990, Cancer research.
[152] G. Koning,et al. On the mechanism of hepatic transendothelial passage of large liposomes , 1999, FEBS letters.
[153] S. Davis,et al. Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan‐stimulated rats , 1993, Journal of leukocyte biology.
[154] W. Oyen,et al. Technetium-99m labelled liposomes to image experimental arthritis , 1997, Annals of the rheumatic diseases.
[155] R. Hunter,et al. The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers. , 1984, Journal of immunology.
[156] S. M. Moghimi. Prolonging the circulation time and modifying the body distribution of intravenously injected polystyrene nanospheres by prior intravenous administration of poloxamine-908. A 'hepatic-blockade' event or manipulation of nanosphere surface in vivo? , 1997, Biochimica et biophysica acta.
[157] M. Pangburn,et al. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[158] P. Arese,et al. Enhanced IgG‐ and complement‐independent phagocytosis of sulfatide‐enriched human erythrocytes by human monocytes , 1992, FEBS letters.
[159] Alving Cr,et al. Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atherosclerosis and autoimmunity. , 1991 .
[160] S. Moghimi,et al. Exploiting bone marrow microvascular structure for drug delivery and future therapies , 1995 .
[161] Robert B Sim,et al. Pattern of degradation of human complement fragment, C3b , 1981, FEBS letters.
[162] C. Nast,et al. Oxygen-dependent up-regulation of mucoid exopolysaccharide (alginate) production in Pseudomonas aeruginosa , 1990, Infection and immunity.
[163] K. Maruyama,et al. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). , 1992, Biochimica et biophysica acta.
[164] Lawrence Mayer,et al. Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel , 1997, Anti-cancer drugs.
[165] S. Jiang,et al. Roles of a macrophage receptor with collagenous structure (MARCO) in host defense and heterogeneity of splenic marginal zone macrophages. , 1999, Archives of histology and cytology.
[166] V. Torchilin,et al. Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo , 1991, FEBS letters.
[167] T. Okano,et al. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. , 1991, Cancer research.
[168] B. Harvey,et al. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ , 1997, Journal of virology.
[169] P. Cullis,et al. β2-Glycoprotein I Is a Major Protein Associated with Very Rapidly Cleared Liposomes in Vivo, Suggesting a Significant Role in the Immune Clearance of "Non-self" Particles (*) , 1995, The Journal of Biological Chemistry.
[170] V. Kolb-Bachofen,et al. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. , 1993, Biochimica et biophysica acta.
[171] D. Papahadjopoulos,et al. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. , 1999, Pharmacological reviews.
[172] S. Kumar,et al. Heterogeneity in endothelial cells from large vessels and microvessels. , 1987, Differentiation; research in biological diversity.
[173] Dunn Se. Biodegradable nanosphere systems for drug targeting : with emphasis on systems for bone marrow targeting. , 1995 .
[174] S. Davis,et al. An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. , 1993, Biochimica et biophysica acta.
[175] T. Kowalewski,et al. Water-Soluble Knedel-like Structures: The Preparation of Shell-Cross-Linked Small Particles , 1996 .
[176] S. Perren,et al. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). , 1993, Journal of biomedical materials research.
[177] Yoshiharu Doi,et al. Thermal degradation of microbial copolyesters: poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and poly(3-hydroxybutyrate-co-4-hydroxybutyrate) , 1990 .
[178] M. Jones,et al. Polymeric micelles - a new generation of colloidal drug carriers. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[179] T. Sodeman,et al. Pitting Function of the Spleen in Malaria: Ultrastructural Observations , 1972, Science.
[180] S. Lee,et al. Macrophage plasma membrane and secretory properties in murine malaria. Effects of Plasmodium yoelii blood-stage infection on macrophages in liver, spleen, and blood , 1986, The Journal of experimental medicine.
[181] V. Fischetti,et al. Variation in the expression of cell wall proteins of Staphylococcus aureus grown on solid and liquid media , 1988, Infection and immunity.
[182] V. Torchilin,et al. Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo. , 1994, Biochimica et biophysica acta.
[183] W. Oyen,et al. Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. , 1999, Biochimica et biophysica acta.
[184] N. Mullah,et al. Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains. , 1997, Bioconjugate chemistry.
[185] M P Bevilacqua,et al. Endothelial-leukocyte adhesion molecules. , 1993, Annual review of immunology.
[186] C. G. Gebelein,et al. Biomedical and Dental Applications of Polymers , 1981 .
[187] J. Kohn,et al. Trends in the Development of Bioresorbable Polymers for Medical Applications , 1992, Journal of biomaterials applications.
[188] P. Flandroy,et al. Control of the biodegradation rate of poly (dl-lactide) microparticles intended as chemoembolization materials , 1996 .
[189] Robert M. Ziff,et al. Kinetics of polymer degradation , 1986 .
[190] B. Tromberg,et al. Fluorescence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissue. , 1996, Cancer research.
[191] T. Snook. A comparative study of the vascular arrangements in mammalian spleens. , 1950, The American journal of anatomy.
[192] C. Lagenaur,et al. Role of CD47 as a marker of self on red blood cells. , 2000, Science.
[193] M. Schmidt,et al. The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. , 1981, European journal of biochemistry.
[194] E. W. Meijer,et al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[195] J. Healey,et al. Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[196] N. Phillips,et al. Immunoliposome targeting to murine CD4+ leucocytes is dependent on immune status. , 1994, Journal of immunology.
[197] N. Narula,et al. Anti-KCA-3, a monoclonal antibody reactive with a rat complement C3 receptor, distinguishes Kupffer cells from other macrophages. , 1993, Journal of immunology.
[198] S. Benita,et al. Variation of Population Release Kinetics in Polydisperse Multiparticulate Systems (Microcapsules, Microspheres, Droplets, Cells) with Heterogeneity of One, Two or Three Parameters in the Population of Individuals , 1988, The Journal of pharmacy and pharmacology.
[199] J. Murray,et al. Activation of Complement by Fluosol Attributable to the Pluronic Detergent Micelle Structure , 1993, Journal of cardiovascular pharmacology.
[200] S. Moghimi,et al. Variation of complement activation in human serum by Poloxamer 188 (Pluronic-F68) , 2001 .
[201] Ulrich Keilholz,et al. Immunohistochemical analysis of integrin αvβ3 expression on tumor‐associated vessels of human carcinomas , 1997 .
[202] S. Davis,et al. The polyoxyethylene/polyoxypropylene block co‐polymer Poloxamer‐407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow , 1992, FEBS letters.
[203] F M Muggia,et al. Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. , 1998, Journal of the National Cancer Institute.
[204] R. Hunter,et al. Induction of macrophage Ia expression in vivo by a synthetic block copolymer, L81. , 1990, Journal of immunology.
[205] D. Williams,et al. Molecular biointeractions of biomedical polymers with extracellular exudate and inflammatory cells and their effects on the biocompatibility, in vivo. , 1994, Biomaterials.
[206] S. Goerdt,et al. A monoclonal antibody reacting with endothelial cells of budding vessels in tumors and inflammatory tissues, and non‐reactive with normal adult tissues , 1986, International journal of cancer.
[207] R K Jain,et al. Determinants of tumor blood flow: a review. , 1988, Cancer research.
[208] I. Ahmad,et al. Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. , 1993, Cancer research.
[209] L. Huang,et al. Some negatively charged phospholipid derivatives prolong the liposome circulation in vivo. , 1992, Biochimica et biophysica acta.
[210] T. Allen. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system , 1994 .
[211] K. Lowe,et al. Evaluation of commercial and purified Pluronic F-68 in a human blood neutrophil bioassay. , 1999, Artificial cells, blood substitutes, and immobilization biotechnology.
[212] S. Davis,et al. Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. , 1994, Critical reviews in therapeutic drug carrier systems.
[213] K. Caldwell,et al. Surface Properties of Pluronic-Coated Polymeric Colloids , 1994 .
[214] Z. Y. Wang,et al. Disposition in rats of a polyoxypropylene-polyoxyethylene copolymer used in plasma fractionation. , 1975, Drug metabolism and disposition: the biological fate of chemicals.
[215] G. Scherphof,et al. Intrahepatic uptake and processing of intravenously injected small unilamellar phospholipid vesicles in rats. , 1984, Biochimica et biophysica acta.
[216] J. Richmond,et al. Enhancement, by Two Carboxylic Acid Interferon Inducers, of Resistance Stimulated in Mice by Foot-and-Mouth Disease Vaccine , 1973, Infection and immunity.
[217] C. M. Gupta,et al. Tuftsin-bearing liposomes in treatment of macrophage-based infections. , 2000, Advanced drug delivery reviews.
[218] A. Gabizon,et al. Liposome circulation time and tumor targeting: implications for cancer chemotherapy , 1995 .
[219] E. Schacht,et al. Preparation and in vitro characterization of HSA-mPEG nanoparticles. , 1999, International journal of pharmaceutics.
[220] M. Gertsenstein,et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. , 1994, Genes & development.
[221] R. Mandrell,et al. Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants. , 1982, Journal of immunology.
[222] G. Hofstede,et al. Liposomal doxorubicin‐induced toxicity: Depletion and impairment of phagocytic activity of liver macrophages , 1995, International journal of cancer.
[223] M. Woodle,et al. Sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.
[224] K. Caldwell,et al. Chemical modification of surface active poly(ethylene oxide)-poly (propylene oxide) triblock copolymers. , 1996, Bioconjugate chemistry.
[225] M A Tracy,et al. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. , 1999, Biomaterials.
[226] S. Benita,et al. Direct measurements on individual microcapsule dissolution as a tool for determination of release mechanism , 1986, The Journal of pharmacy and pharmacology.
[227] A. Tulpule,et al. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[228] M. Lifely,et al. Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide , 1985, Infection and immunity.
[229] M. Keltai,et al. The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarction. , 1997, Clinical hemorheology and microcirculation.
[230] L. Huang,et al. Large liposomes containing ganglioside GM1 accumulate effectively in spleen. , 1991, Biochimica et biophysica acta.
[231] P. Volberding,et al. Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma , 1996, Journal of clinical pharmacology.
[232] S. Davis,et al. The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338) , 1984, FEBS letters.
[233] T. Gray,et al. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes , 1994, FEBS letters.
[234] C. Mold,et al. Effect of gangliosides on activation of the alternative pathway of human complement. , 1988, Journal of immunology.
[235] Abrams Rm,et al. Liposome disposition in vivo: effects of pre-dosing with lipsomes. , 1980 .
[236] Humoral-mediated recognition of 'phagocyte-resistant' beads by lymph node macrophages of poloxamine-treated rats. , 1998, Clinical science.
[237] Y. Barenholz,et al. Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[238] D. Crommelin,et al. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose. , 1997, Biochimica et biophysica acta.
[239] P. Densen,et al. Phagocyte strategy vs. microbial tactics. , 1980, Reviews of infectious diseases.
[240] R. Horstmann,et al. Location of the complement factor H binding site on streptococcal M6 protein , 1995, Infection and immunity.
[241] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.
[242] G. Gregoriadis,et al. Polysialic acids: potential in drug delivery , 1993, FEBS letters.
[243] B. Bennett,et al. The Adjuvant Activity of Nonionic Block Polymer Surfactants , 1986, Scandinavian journal of immunology.
[244] T. K. van den Berg,et al. Manipulation of Macrophage Activities Using Liposomes , 2000 .
[245] H. Morselt,et al. Secretion pattern of the rat liver macrophage population following activation with liposomal muramyl dipeptide in vivo and in vitro. , 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[246] T. Allen,et al. Insertion of poly(ethylene glycol) derivatized phospholipid into pre‐formed liposomes results in prolonged in vivo circulation time , 1996, FEBS letters.
[247] M. Kazatchkine,et al. Human liver Kupffer cells express CR1, CR3, and CR4 complement receptor antigens. An immunohistochemical study. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[248] G. Kraal. Cells in the marginal zone of the spleen. , 1992, International review of cytology.
[249] B. Goins,et al. Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[250] T. Allen,et al. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. , 1991, Biochimica et biophysica acta.
[251] Daniel Dexter,et al. An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel , 1997, Cancer Chemotherapy and Pharmacology.
[252] F. Emmrich,et al. Apoptotic cell death in activated monocytes following incorporation of clodronate‐liposomes , 1996, Journal of leukocyte biology.
[253] S. Bhatia,et al. Enhancement of the in vivo circulation lifetime of L-alpha-distearoylphosphatidylcholine liposomes: importance of liposomal aggregation versus complement opsonization. , 1997, Biochimica et biophysica acta.
[254] D. Friend,et al. Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. , 1992, Cancer research.
[255] M. Cybulsky,et al. Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[256] T. Chang,et al. Comparison of polymerically stabilized PEG-grafted liposomes and physically adsorbed carboxymethylchitin and carboxymethyl/glycolchitin liposomes for biological applications. , 1998, Biomaterials.
[257] P. A. Martic,et al. Protein adsorption on pluronic copolymer-coated polystyrene particles , 1989 .
[258] L. Huang,et al. Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen. , 1992, Biochimica et biophysica acta.
[259] K. Wirtz,et al. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers , 1979, Nature.
[260] A. Gabizon,et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[261] L. Andrac,et al. ELAM selectin expression in breast carcinomas detected by automated and quantitative immunohistochemical assays. , 1998, International journal of oncology.
[262] V. Torchilin,et al. Stable polymeric micelles: lymphangiographic contrast media for gamma scintigraphy and magnetic resonance imaging. , 1996, Academic radiology.
[263] P. Cullis,et al. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. , 1992, The Journal of biological chemistry.
[264] P. Cullis,et al. Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles. , 1994, Biochimica et biophysica acta.
[265] T. Allen,et al. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. , 1989, Biochimica et biophysica acta.
[266] Teruo Okano,et al. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-Adriamycin conjugates , 1994 .
[267] J. Murray,et al. Phagocytic activation of human neutrophils by the detergent component of fluosol. , 1992, The American journal of pathology.
[268] J. Sunamoto,et al. Surface Coating of Liposomes with Hydrophobized Polysaccharides , 1997 .
[269] C. Passirani,et al. Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). , 1998, Pharmaceutical research.
[270] M. Woodle,et al. New amphipatic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes. , 1994, Bioconjugate chemistry.
[271] J. Rosenecker,et al. Increased liposome extravasation in selected tissues: effect of substance P. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[272] P. Couvreur,et al. Stability of orosomucoid-coated polyisobutylcyanoacrylate nanoparticles in the presence of serum , 1996 .
[273] L. Weiss,et al. The role of the sinus wall in the passage of erythrocytes through the spleen. , 1973, Blood.
[274] Patrick Couvreur,et al. Synthesis of a Novel Poly(MePEG cyanoacrylate-co-alkyl cyanoacrylate) Amphiphilic Copolymer for Nanoparticle Technology‡ , 1997 .
[275] Y. M. Lee,et al. Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[276] R. Melton,et al. Covalent linkage of carboxypeptidase G2 to soluble dextrans--II. In vivo distribution and fate of conjugates. , 1987, Biochemical pharmacology.
[277] P. Caliceti,et al. New synthetic amphiphilic polymers for steric protection of liposomes in vivo. , 1995, Journal of pharmaceutical sciences.
[278] M. Dierich,et al. Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3d but not C3b , 1985, Infection and immunity.
[279] K. K. Modowal,et al. Mortality of patients with acute myocardial infarction. , 1973, Current medical research and opinion.
[280] D. Absolom. [13] Opsonins and dysopsonins: An overview , 1986 .
[281] L. T. Chen. Intrasplenic microcirculation in rats with acute hemolytic anemia. , 1980, Blood.
[282] N. Copeland,et al. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[283] H. Bengele,et al. Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration. , 1994, Magnetic resonance imaging.
[284] M. Woodle,et al. Peptide attachment to extremities of liposomal surface grafted PEG chains: preparation of the long-circulating form of laminin pentapeptide, YIGSR. , 1995, Bioconjugate chemistry.
[285] S. M. Moghimi. Re-establishing the long circulatory behaviour of poloxamine-coated particles after repeated intravenous administration: applications in cancer drug delivery and imaging. , 1999, Biochimica et biophysica acta.
[286] R. Cotran,et al. Cytokines and endothelial cell biology. , 1990, Physiological reviews.
[287] M C Davies,et al. Poly(organo phosphazene) nanoparticles surface modified with poly(ethylene oxide). , 1996, Biotechnology and bioengineering.
[288] J. Baker,et al. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[289] S. Shreeve,et al. Heterogeneity of vascular endothelial cells in normal and disease states. , 1998, Pharmacology & therapeutics.
[290] A. Gabizon,et al. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[291] S. Davis,et al. Lymph node localisation of biodegradable nanospheres surface modified with poloxamer and poloxamine block co‐polymers , 1997, FEBS letters.
[292] P. Lin,et al. Effect of tumour necrosis factor, heat, and radiation on the viability and microfilament organization in cultured endothelial cells. , 1992, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[293] D. Drenckhahn,et al. Stress fibers in the splenic sinus endothelium in situ: molecular structure, relationship to the extracellular matrix, and contractility , 1986, The Journal of cell biology.
[294] I. Ahmad,et al. Immunoliposome-mediated targeting of anti-cancer drugs in vivo. , 1995, Biochemical Society transactions.
[295] T. Allen,et al. Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. , 1991, Biochimica et biophysica acta.
[296] F. Veronese,et al. Stabilization of substances in circulation. , 1998, Bioconjugate chemistry.
[297] エマニユエル,アール・マーテイン,et al. Polyoxypropylene / polyoxyethylene copolymers with improved biological activity , 1992 .
[298] F. Braet,et al. Structure and dynamics of the fenestrae‐associated cytoskeleton of rat liver sinusoidal endothelial cells , 1995, Hepatology.
[299] A. Groom,et al. The Microcirculatory Society Eugene M. Landis award lecture. Microcirculation of the spleen: new concepts, new challenges. , 1987, Microvascular research.
[300] M. Woodle,et al. Controlling liposome blood clearance by surface-grafted polymers. , 1998, Advanced drug delivery reviews.
[301] D. Tzemach,et al. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[302] M. Davies,et al. Differences in the molecular weight profile of poloxamer 407 affect its ability to redirect intravenously administered colloids to the bone marrow , 1992 .
[303] I. Bakker-Woudenberg,et al. Toxicity of doxorubicin entrapped within long-circulating liposomes , 1997 .
[304] F. Jamar,et al. A comparison between 111In-anti-E-selectin mAb and 99Tcm-labelled human non-specific immunoglobulin in radionuclide imaging of rheumatoid arthritis. , 1997, The British journal of radiology.
[305] K. Alitalo,et al. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? , 1998, The American journal of pathology.
[306] S. Zalipsky. Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. , 1995, Bioconjugate chemistry.
[307] J. White,et al. Pluronic F-68 reduces the endothelial adherence and improves the rheology of liganded sickle erythrocytes. , 1987, Blood.
[308] T. Gray,et al. A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats. , 1997, Clinical science.
[309] Y. Yarden,et al. Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies. , 1996, British Journal of Cancer.
[310] N. Bjoerkman,et al. ULTRASTRUCTURAL ALTERATIONS IN SINUSOIDAL ENDOTHELIUM OF LIVER AND BONE MARROW IN DOGS WITH EXPERIMENTAL HEPATITIS CONTAGIOSA CANIS. , 1964, Acta pathologica et microbiologica Scandinavica.
[311] H. Kehlen,et al. Continuous kinetics of first order degradation reactions in polydisperse mixtures , 1988 .
[312] T. Okano,et al. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. , 1990, Cancer research.
[313] W. Bochenek,et al. Absorption and excretion of the hydrophobic surfactant, 14C-poloxalene 2930, in the rat. , 1984, Drug metabolism and disposition: the biological fate of chemicals.
[314] H M Patel,et al. Serum opsonins and liposomes: their interaction and opsonophagocytosis. , 1992, Critical reviews in therapeutic drug carrier systems.
[315] R. Jain,et al. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. , 1994, Cancer research.
[316] M. Bally,et al. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol). , 1997, The Journal of pharmacology and experimental therapeutics.
[317] C. Hulstaert,et al. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride–induced elimination and repopulation , 1992, Journal of leukocyte biology.
[318] W. Lin. The preparation and characterization of surface modified albumin nanoparticles for site specific drug delivery. , 1996 .
[319] K. Lowe,et al. Purification of Pluronic F‐68 for perfluorochemical emulsification * , 1989, The Journal of pharmacy and pharmacology.
[320] S. Moghimi,et al. Advanced colloid-based systems for efficient delivery of drugs and diagnostic agents to the lymphatic tissues. , 1996, Progress in biophysics and molecular biology.
[321] F. Martin,et al. Liposome leakage and blood circulation: Comparison of adsorbed block copolymers with covalent attachment of PEG , 1992 .
[322] S. Gordon,et al. Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody , 1989, The Journal of experimental medicine.
[323] Kazuo Maruyama,et al. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.
[324] S. Kennel,et al. Lipid composition is important for highly efficient target binding and retention of immunoliposomes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[325] S. Rössner,et al. The influence of emulsifying agents and of lipid soluble drugs on the fractional removal rate of lipid emulsions from the blood stream of the rabbit. , 2009, Acta pharmacologica et toxicologica.
[326] B. Baguley,et al. Plasma half-life of cytosine arabinoside (NSC-63878) in patients treated for acute myeloblastic leukemia. , 1971, Cancer chemotherapy reports.
[327] John W. Park,et al. Development of anti-p185HER2 immunoliposomes for cancer therapy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[328] A. Griffioen,et al. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. , 2000, Pharmacological reviews.
[329] Suming Li,et al. Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. , 1995, Biomaterials.
[330] A. U. Daniels,et al. Mechanical properties of biodegradable polymers and composites proposed for internal fixation of bone. , 1990, Journal of applied biomaterials : an official journal of the Society for Biomaterials.
[331] G. Nicolson,et al. Differential expression of cell surface glycoproteins on various organ‐derived microvascular endothelia and endothelial cell cultures , 1988, Journal of cellular physiology.
[332] N. Oku,et al. Liposomal modification with uronate, which endows liposomes with long circulation in vivo, reduces the uptake of liposomes by J774 cells in vitro. , 1992, Life sciences.
[333] W. Oyen,et al. 99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[334] Y. Lee,et al. Methoxy poly(ethylene glycol)/?-caprolactone amphiphilic block copolymeric micelle containing indome , 1998 .
[335] Bing Li,et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.
[336] N. Oku,et al. Long-circulating liposomes. , 1994, Critical reviews in therapeutic drug carrier systems.
[337] N. Oku,et al. Tumor accumulation of novel RES-avoiding liposomes. , 1992, Biochimica et biophysica acta.
[338] R Pasqualini,et al. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. , 1998, The Journal of clinical investigation.
[339] T M Allen,et al. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.
[340] S. Perren,et al. The effect of melt-processing on the degradation of selected polyhydroxyacids: polylactides, polyhydroxybutyrate, and polyhydroxybutyrate-co-valerates , 1993 .
[341] L. Lowe-Krentz,et al. Identification of a heparin-binding protein using monoclonal antibodies that block heparin binding to porcine aortic endothelial cells. , 1995, The Biochemical journal.
[342] H. Lutz,et al. The Role of Complement Activation in Hypersensitivity to Pegylated Liposomal Doxorubicin (Doxil®) , 2000 .
[343] M S Newman,et al. Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes. , 1997, Biochimica et biophysica acta.
[344] R. Sellers,et al. The effect of a synthetic anionic polymer (pyran) on the development of foot-and-mouth disease in guinea-pigs, cattle and pigs. , 1972, Research in veterinary science.
[345] S. Meri,et al. Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H. , 1994, Biochemical and biophysical research communications.
[346] P. Couvreur,et al. Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol). , 1997, Journal of biomedical materials research.
[347] Bally,et al. Clearance properties of liposomes involving conjugated proteins for targeting. , 1998, Advanced drug delivery reviews.
[348] Baguley Bc,et al. Plasma half-life of cytosine arabinoside (NSC-63878) in patients treated for acute myeloblastic leukemia. , 1971 .
[349] Z. Cohn,et al. The macrophage. , 1973, International review of cytology.
[350] L. Weiss. Barrier cells in the spleen. , 1991, Immunology today.
[351] L. Mayer,et al. Applications of Liposome Technology to Overcome Multidrug Resistance in Solid Tumors , 1998 .
[352] D. Knook,et al. Relation between localization and function of rat liver Kupffer cells. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[353] H. Yamanaka,et al. In vivo controlled release of a luteinizing hormone-releasing hormone agonist from poly(dl-lactic acid) formulations of varying degradation pattern , 1991 .
[354] L. Weiss,et al. Species variation in the structure and function of the marginal zone--an electron microscope study of cat spleen. , 1981, The American journal of anatomy.
[355] Antonio Alcami,et al. Viral mechanisms of immune evasion , 2000, Immunology Today.
[356] J. Gazzola,et al. Determination of coating thickness of microcapsules and influence upon diffusion. , 1973, Journal of pharmaceutical sciences.
[357] J. Ritz,et al. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. , 1982, Cancer research.
[358] W. Regelson,et al. The Anionic Polyelectrolyte, Polyethylene Sulphonate, as a New Anti-neoplastic Agent , 1958, Nature.
[359] J. Swanson,et al. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages , 1996, The Journal of cell biology.
[360] R. Souhami,et al. The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes. , 1981, Biochimica et biophysica acta.
[361] Chong-Su Cho,et al. METHOXY POLY(ETHYLENE GLYCOL) AND CAPROLACTONE AMPHIPHILIC BLOCK CO POLYMERIC MICELLE CONTAINING INDOMETHACIN. II: MICELLE FORMATION AND DRUG RELEASE BEHAVIORS , 1998 .
[362] G Blume,et al. Liposomes for the sustained drug release in vivo. , 1990, Biochimica et biophysica acta.